Skip to NavigationSkip to content

News

0
Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in the US, as it...
0
The Scottish Medicines Consortium has awarded approval to Santen's eye drops emulsion Verkazia for the treatment of severe vernal...
0
American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access to clinical...
0
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData.

Features

In November 2018, a Phase 2 clinical trial foundthat 76% of patients who underwent MDMA-assisted psychotherapy no longer had PTSD, twelve months...